Skip to ContentSkip to Navigation
About us Latest news News News articles

The foundation of Prince Bernhard Junior donates to research of the UG

08 March 2017

The researchers Joost Kluiver and Anke van den Berg have been awarded with a grant worth €772,000 from the Lymph&Co foundation for research into lymphoma. Central to this research is a recently discovered major network of genes that strongly influences the growth of lymph node cancer cells. The aim of the researchers is to gain more insight in this network and the genes and they hope to gain more understanding of the process of the disease. Moreover, they hope to find new leads for the development of alternative therapeutic approaches.

The Lymph&Co foundation was initiated by Bernhard van Oranje, alumnus of the UG, who was diagnosed with lymphoma in 2013. The donation of Lymph & Co is made available through the Ubbo Emmius Fund of the UG. The research is conducted at the Department of Pathology of the University Medical Center Groningen (UMCG).

On March 5th, Anke van den Berg and Joost Kluiver received the first cheque of €372,897 by Bernhard van Oranje and Marie-José Helle, director of Lymph&Co. The cheque was presented at 'De Hollandse 100’, an annual sponsor event by Lymph&Co. (FLTR: Bernhard van Oranje, Marie-José Helle, Anke van den Berg, Joost Kluiver)
On March 5th, Anke van den Berg and Joost Kluiver received the first cheque of €372,897 by Bernhard van Oranje and Marie-José Helle, director of Lymph&Co. The cheque was presented at 'De Hollandse 100’, an annual sponsor event by Lymph&Co. (FLTR: Bernhard van Oranje, Marie-José Helle, Anke van den Berg, Joost Kluiver)

Lymphoma


The Lymph&Co foundation aims to promote scientific research into the development and treatment of lymphoma and also wants to generate more attention for this type of cancer. Lymphoma is a cancer of the white blood cells. Although in recent years the treatments have been improved, every year many patients pass away because of the disease or the effects of intensive treatments. It is clear that there is still a great need for new, more effective therapies with fewer side effects and less negative consequences in the long term. In order to make this possible, it is important to correctly understand the change of the cellular processes in the tumor cells.

About the Ubbo Emmius Fund


Especially for its fundraising, the University established the Ubbo Emmius Fund (UEF). The UEF encourages mutual commitment between society and the University by organizing activities for alumni and relations and raise funds for research and education at the University. The UEF is recognized as a public benefit institution (in Dutch: ANBI).

Last modified:14 April 2020 11.32 a.m.
printView this page in: Nederlands

More news